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ABSTRACT 
Objective: Neurodegenerative diseases, such as dementia, have a profound impact on those 
with the conditions and their family carers. Consequently, the accurate measurement of family 
carers’ quality of life (QOL) is important. Generic measures may miss key elements of the 
impact of these conditions so using disease-specific instruments has been advocated. This 
systematic review aimed to identify and examine the psychometric properties of disease-
specific outcome measures of QOL of family carers of people with neurodegenerative diseases 
(Alzheimer’s disease, other dementias; Huntington’s disease; Parkinson’s disease; Multiple 
Sclerosis; and Motor Neurone Disease). 
Design: Systematic review.   
Methods: Instruments were identified using five electronic databases (PubMed, PsycINFO, 
Web of Science, Scopus and IBSS) and lateral search techniques. Only studies which reported 
the development and/or validation of a disease-specific measure for adult family carers, and 
which were written in English, were eligible for inclusion. The methodological quality of the 
included studies was evaluated using the COSMIN checklist. The psychometric properties of 
each instrument were examined.  
Results: Six hundred and seventy six articles were identified. Following screening and lateral 
searches, a total of eight articles were included; these reported seven disease-specific carer 
QOL measures. Limited evidence was available for the psychometric properties of the seven 
instruments. Psychometric analyses were mainly focused on internal consistency, reliability 
and construct validity. None of the measures assessed either criterion validity or responsiveness 
to change.         
Conclusions: There are very few measures of carer QOL that are specific to particular 
neurodegenerative diseases. The findings of this review emphasise the importance of 
developing and validating psychometrically robust disease-specific measures of carer QOL. 
  
 
3 
 
STRENGTHS AND LIMITATIONS OF THIS STUDY  
 
 This study provides the first comprehensive review of disease-specific instruments 
measuring quality of life of family carers of people with neurodegenerative diseases. 
 The findings of the review offer guidance to researchers and clinicians in the selection 
of appropriate and psychometrically strong disease-specific instruments. 
 Only instruments specific to neurodegenerative diseases were examined. 
 We did not review the performance of generic measures of quality of life. 
 The instruments identified in this review were developed specifically for family carers 
rather than professional (i.e. paid) carers of people with neurodegenerative diseases.        
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INTRODUCTION 
Neurodegenerative diseases have a profound impact as they lead to a prolonged and 
irreversible decline in global intellectual, social, and physical functioning.  People living with 
neurodegenerative diseases tend to progressively lose their independence and require 
increased levels of care and support. Dementia is the most common type of 
neurodegenerative disease, affecting 800,000 people in the UK alone, [1] and costing £26.3 
billion to society each year. [2] Family members, friends and neighbours who act as carers 
are a vital determinant of positive outcomes for people with neurodegenerative diseases such 
as dementia. They provide a wide range of practical and emotional support, social care, and 
assistance with activities of daily living. [3] These caregiving tasks include, for example, help 
with personal care, managing finances and legal affairs, social activities, mobility, and 
administering and co-ordinating medication. [3] 
Caring for a person with a neurodegenerative disease may result in multiple negative 
outcomes, including increased anxiety and depression, stress, exhaustion, social isolation, and 
concerns about the future. [1] Nevertheless, caring can also have positive effects such as 
greater closeness to the person with the condition, reciprocity, and spiritual growth. [4, 5, 6] 
In recent years, there has been an increasing research focus on assessing Quality of Life 
(QOL) as an informative and important patient-reported outcome measure in the person with 
the disease and their carers. Although QOL is subjective in regards to how it is perceived by 
the individual, there is growing consensus that it represents a multidimensional construct 
encompassing various domains such as physical health, socio-economic status; 
psychological, emotional and social wellbeing, and that it is a useful way of capturing the 
broad impacts of complex disorders such as neurodegenerative disease. [7] In this paper, 
following the recommendations of our carer consultation, the term “family carer” is used to 
refer to all ‘informal’ carers (i.e. not paid carers), including family members, neighbours and 
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friends of a person with a neurodegenerative disease. This also includes people who are not, 
in fact, family members, since the term ‘informal’ was seen as minimising and trivialising the 
nature of the care provided, and the term ‘carer’ by itself was seen as too imprecise.  
Given the important role of family carers, it is essential for both the person with the 
illness as well as for the carer, that carers of people with neurodegenerative diseases maintain 
a good QOL. Carer QOL is likely to be associated with patient QOL, and when carer QOL 
deteriorates, there is likely to be a higher risk that the person with dementia will need 
admission into a care home, so driving lower life quality and higher societal cost. It is also 
important to measure the broad QOL carer impacts of interventions for the person with 
dementia and for carers. To ensure this can be monitored effectively, it is necessary to 
measure carer QOL accurately using psychometrically robust measures. To date, QOL of 
both affected individuals and their carers has been predominantly assessed using generic 
health status instruments such as the SF-36 [8] and the EQ-5D. [9] Disease-specific 
instruments have been used much less frequently. This is problematic as generic instruments 
miss issues that are pertinent to specific conditions and, consequently, are less responsive to 
detecting changes in carer QOL over time. [10, 11] For example, an increased level of 
support received as a carer has been associated with better carer QOL in dementia, [4] but 
neither the EQ-5D nor the SF-36 capture such a construct. 
An earlier review has examined the effects (e.g. physical, social, emotional, financial) 
of caring for an elderly family member with dementia on carer QOL. [11] Disease-specific 
and generic instruments were identified that assess QOL of either dementia patients or their 
carers. However, the psychometric properties of these measures were not reported or 
discussed, and the review focussed exclusively on dementia and Alzheimer’s disease. 
Building on this, we therefore completed a systematic review to identify and examine the 
disease-specific instruments that measure QOL of family carers of people with a 
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neurodegenerative disease. Here we examine the psychometric properties of these 
instruments.  
METHODS 
The systematic review was conducted and reported in accordance with the 
recommendations from the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement. [12]       
 
Inclusion Criteria 
Instruments were included in the review if they satisfied the following criteria: (1) the 
study described the development (‘inauguration paper’) and/or the evaluation of the 
psychometric properties and relationships with other relevant constructs (‘validation paper’) 
of a measure of carer QOL; (2) the study population were adult (aged 18 years or above) 
family (defined as family members, neighbours or friends) carers of people with a 
neurodegenerative disease (Dementia, Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease, Multiple Sclerosis, and Motor Neurone Disease); (3) the instrument 
was designed to be disease-specific and not a generic measure of QOL; (4) studies only 
documented instruments that were self-report in their design. Any studies that reported an 
eligible measure (e.g. as an outcome in a clinical trial) without any explicit validation were 
excluded; and (5) studies were written in English.    
 
Search Strategy 
Articles were identified from initial searches of five electronic databases: PubMed, 
PsycINFO, Scopus, Web of Science, and the International Bibliography of the Social 
Sciences (IBSS). The searches were conducted from inception until 08 February 2016. All 
articles identified up until this time were screened regardless of their publication date. We 
used the following five combined sets of search terms: (1) “quality of life”; AND (2) 
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caregiver* OR carer*; AND (3) informal OR unpaid OR spous* OR family; AND (4) 
dementia OR alzheimer* OR parkinson* OR huntington* OR multiple sclerosis OR motor 
neurone disease; AND (5) valid* OR reliab* OR development OR psychometric.  The search 
terms were intentionally broad and sensitive enough to ensure that all potentially relevant 
articles were identified. Six additional articles were obtained using lateral searching 
techniques. [13] These searches involved the manual checking of reference lists of included 
studies (snowballing), citation searches using the ‘Cited by’ option on Web of Science, 
Google Scholar, and Scopus, and the ‘Related articles’ option on PubMed and Web of 
Science (lateral searching). The grey literature (i.e. unpublished studies) was also searched 
using the following databases: OpenGrey and Patient-Reported Outcome and Quality of Life 
Instruments Database (PROQOLID). We attempted to make direct contact (via email) with 
the authors of a manuscript when no published psychometric data were available for the 
instrument being reported. Two independent reviewers (TEP & NF) screened article titles and 
abstracts against the predefined inclusion criteria. Full-text articles were sought for all 
potentially relevant studies. Any disagreements concerning inclusion were resolved through 
discussion and advice from a third reviewer (SD). 
 
Data Extraction 
Two reviewers (TEP & NF) extracted, independently, the following data for studies 
that met the inclusion criteria: name of the instrument, country, sample characteristics 
(gender, age), study design/setting, measurement domains, number of items, response format, 
evidence of reliability and validity.     
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Quality Assessment  
The methodological quality of the studies was assessed using the COnsensus based 
Standards for the selection of health Measurement Instruments (COSMIN) checklist. [14–16] 
This is a standardized tool which assesses the measurement properties of health-related 
instruments across nine domains (internal consistency, reliability, measurement error, content 
validity [including face validity], construct validity [subdivided into structural validity, 
hypotheses testing, and cross-cultural validity], criterion validity and responsiveness) with 
each domain rated using 5-18 items. Each item is rated as ‘excellent’, ‘good’, ‘fair’, or ‘poor’ 
quality. A methodological quality score for each measurement property is obtained by taking 
the lowest rating of any item in that box (“worst score counts”). Two independent reviewers 
(TEP & NF) assessed the methodological quality of the included studies using the checklist. 
Any disagreements in scoring were resolved through discussion and advice from a third 
reviewer (SD).                 
 
RESULTS 
Search Results  
The initial database searches identified 676 articles, of which 232 were removed 
following deletion of duplicates. After title and abstract screening, we assessed seven articles 
as potentially relevant and obtained full-texts. From reviewing the full-texts of these 
remaining articles, we found two studies that met inclusion criteria (Figure 1). Six additional 
articles were identified using lateral search techniques. 
In total, we included 8 studies in the systematic review and these reported 7 carer 
QOL instruments across the neurodegenerative diseases. All were self-report measures and 
consisted of the Huntington disease quality-of-life battery for carers, [HDQoL-C; 17] 
Huntington disease quality-of-life battery for carers- short form, [HDQoL-C-SF; 18] 
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CAREQOL-MS for Multiple Sclerosis, [19] Alzheimer’s Carers Quality of Life Instrument, 
[ACQLI; 20] Parkinson Disease Questionnaire for Carers, [PDQ-Carer; 21] Parkinsonism 
Carers QoL, [PQoL Carers; 22] and the Caregiver Quality Of Life for dementia. [CGQOL; 6] 
We did not identify any instruments designed to measure the QOL of carers of people with 
motor neurone disease.  
 
Study Characteristics  
The sample characteristics for the 8 studies assessing the carer QOL instruments are 
presented in Table 1. 
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Table 1. Characteristics of the included studies  
Carer QOL Instrument Author(s) Country Sample 
Total N (% female) 
Mean age years 
(S.D.) 
Study Design/Setting Measurement Domains No. of 
Items/Response 
Format 
 
Huntington disease 
quality-of-life battery 
for carers (HDQoL-C) 
 
Aubeeluck & 
Buchanan 
(2007) 
 
United 
Kingdom 
 
87 (62.1) 
58.2 (14.2) 
 
Longitudinal/Cohort: 
Spousal carers 
recruited through the 
Huntington’s Disease 
Association UK. 
 
Demographic and objective information; practical 
aspects of caregiving; satisfaction with life; feelings 
about living with Huntington’s Disease 
34 items 
11-point Likert 
scale 
Huntington disease 
quality-of-life battery 
for carers short form 
(HDQoL-C-SF) 
Aubeeluck et 
al. (2012) 
France 
Italy 
301 (60.5) 
57.1 (13.1) 
Cross-sectional 
survey: Family or 
friend carers of people 
with Huntington’s 
Disease. 
Satisfaction with life; feelings about living with 
Huntington’s Disease 
20 items 
11-point Likert 
scale 
 
CAREQOL-MS 
Benito-Leon 
et al. (2011) 
Spain 276 (56.5) 
50.2 (12.6) 
Longitudinal/Cohort: 
Family carers of 
people with Multiple 
Sclerosis recruited 
from 19 Spanish 
outpatient clinics 
Physical burden and global health; social impact; 
emotional impact; need of support; emotional 
reactions to patient’s psychic status. 
24 items 
5-point Likert 
scale 
Alzheimer’s Carers 
Quality of Life 
Instrument (ACQLI) 
Doward 
(1997) 
United 
Kingdom 
France 
Germany 
Italy 
Spain 
192 (72.3) 
60.0 (12.2) 
Longitudinal/Cohort: 
Family carers of 
people with dementia 
Single domain of carer QOL 30 items 
Dichotomous 
(True/Not True) 
 
Parkinson Disease 
Questionnaire for 
Carers (PDQ-Carer) 
 
Jenkinson et 
al. (2012) 
 
United 
Kingdom 
 
236 (63.5) 
68.2 (9.5) 
 
Cross-sectional 
survey: Family carers 
of people with 
Parkinson’s Disease 
who were members of 
Parkinson’s UK. 
 
Social and personal activities; anxiety and 
depression; self-care; stress 
 
29 items 
5-point Likert 
scale  
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Table 1. Characteristics of the included studies (Continued) 
Carer QOL Instrument Author(s) Country Sample 
Total N (% female) 
Mean age years 
(S.D.) 
Study Design/Setting Measurement Domains No. of 
Items/Response 
Format 
 
Parkinson Disease 
Questionnaire for 
Carers Summary 
Index (PDQ-Carer-SI) 
 
Morley et al. 
(2013) 
 
United 
Kingdom 
 
236 (63.5) 
68.2 (9.5) 
 
Cross-sectional 
survey: Family carers 
of people with 
Parkinson’s Disease 
who were members of 
Parkinson’s UK. 
 
Single summary index score computed using the four 
subscales of the PDQ-Carer 
 
29 items 
5-point Likert 
scale 
Parkinsonism Carers 
QoL (PQoL Carers) 
Pillas et al. 
(2016) 
United 
Kingdom 
430 (62.4) 
66.2 (8.5) 
Cross-sectional 
survey: Family carers 
of people with 
multiple system 
atrophy (MSA) and 
progressive 
supranuclear palsy 
(PSP) 
Single domain of carer QOL 26 items 
5-point Likert 
scale 
Caregiver Quality Of 
Life (CGQOL) 
Vickrey et al. 
(2009) 
USA 200 (79.0) 
61.5 (13.5) 
Longitudinal/Cohort: 
Family carers of 
people with dementia 
Assistance with instrumental activities of daily 
living; assistance with activities of daily living; role 
limitations due to caregiving; personal time; family 
interaction; demands of caregiving; worry; 
spirituality and faith; benefits of caregiving; 
caregiver feelings 
80 items  
3-point and 5-
point Likert 
scales specific 
to groups of 
items  
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The total sample sizes of these studies ranged from 87 [17] to 430. [22] The studies recruited 
participants from the United Kingdom, [17, 21, 22, 23, ] Spain [19] and the United States. [6] 
The remaining 2 studies recruited participants across multiple countries which included 
France, Italy, and Germany. [18, 20] The mean age of participants across the 8 studies was 
61.2 years. The number of measurement domains of the instruments ranged from 1 (ACQLI, 
PQoL Carers) to 10 (CGQOL). The number of items of these instruments ranged from 20 
(HDQoL-C-SF) to 80 (CGQOL). All measures used Likert-type rating scales (ranging from 
3-point to 11-point), except for the ACQLI which used a dichotomous (True/Not True) 
response format.    
 
Methodological Quality of Studies  
Table 2 provides a summary of the scores from the COSMIN checklist. Six of the 
eight studies (75%) included in the review had at least one methodological domain rated as 
‘poor’ quality. [6, 17-21] Across all studies, the measurement property that received the 
highest number of ‘poor’ ratings was Content Validity (4/8 studies). Five of the eight studies 
(63%) had at least one methodological domain rated as of ‘fair’ quality. [6, 18, 21-23] The 
measurement property that received the highest number of ‘fair’ ratings was Internal 
Consistency (5/8 studies). Of the eight studies, two (26%) had at least one area of 
methodological quality rated as ‘good’ or ‘excellent.’ [19, 22] The measurement properties 
that received ‘good’ ratings were Reliability and Measurement Error. [19] The measurement 
properties that received ‘excellent’ ratings were Internal Consistency, Structural Validity [19] 
and Content Validity. [22]
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Carer QOL 
instrument 
Study 
reference 
Internal 
consistency 
Reliability Measurement 
error 
Content 
validity 
Structural 
validity 
Hypotheses 
testing 
Cross-cultural 
validity 
Criterion 
validity 
Responsiveness 
Huntington 
disease quality-
of-life battery 
for carers 
(HDQoL-C) 
 
Aubeeluck & 
Buchanan 
(2007) 
 
 
1 
 
 
1 
 
 
0 
 
 
1 
 
 
1 
 
 
0 
 
 
0 
 
 
0 
 
 
0 
 
Huntington 
disease quality-
of-life battery 
for carers short 
form (HDQoL-
C-SF) 
 
 
Aubeeluck et 
al. (2012) 
 
 
2 
 
 
0 
 
 
0 
 
 
0 
 
 
2 
 
 
2 
 
 
1 
 
 
0 
 
 
0 
 
CAREQOL-
MS 
 
Benito-Leon 
et al. (2011) 
 
4 
 
3 
 
3 
 
1 
 
4 
 
0 
 
0 
 
0 
 
0 
 
Alzheimer’s 
Carers Quality 
of Life 
Instrument 
(ACQLI) 
 
 
Doward 
(1997) 
 
 
1 
 
 
1 
 
 
0 
 
 
1 
 
 
0 
 
 
0 
 
 
1 
 
 
0 
 
 
0 
Table 2. Results of COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) Checklist 
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Key. 4: Excellent, 3: Good, 2: Fair, 1: Poor, 0: No information available
Parkinson 
Disease 
Questionnaire 
for Carers 
(PDQ-Carer) 
 
Jenkinson et 
al. (2012) 
 
 
2 
 
 
0 
 
 
0 
 
 
1 
 
 
2 
 
 
0 
 
 
0 
 
 
0 
 
 
0 
 
Parkinson 
Disease 
Questionnaire 
for Carers 
Summary 
Index (PDQ-
Carer-SI) 
 
 
 
Morley et al. 
(2013) 
 
 
2 
 
 
0 
 
 
0 
 
 
0 
 
 
2 
 
 
0 
 
 
0 
 
 
0 
 
 
0 
 
Parkinsonism 
Carers QoL 
(PQoL Carers)  
 
Pillas et al. 
(2016) 
 
2 
 
0 
 
0 
 
4 
 
2 
 
0 
 
0 
 
0 
 
0 
 
Caregiver 
Quality Of Life 
(CGQOL) 
 
Vickrey et al. 
(2009)  
 
 
2 
 
1 
 
0 
 
0 
 
 
1 
 
1 
 
1 
 
0 
 
0 
 
Table 2. Results of COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued) 
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Psychometric Properties of the Carer Quality of Life Instruments  
The instruments that had allowed the most comprehensive evaluation of psychometric 
properties across the nine domains of the COSMIN checklist were the CAREQOL-MS (5/9 
domains assessed) and the CGQOL (5/9 domains assessed). The HDQoL-C, HDQoL-C-SF, 
and ACQLI each had four of the nine domains evaluated. The measures that had the least 
evidence available for their psychometric properties were the PQoL Carers (3/9 domains 
assessed), the PDQ-Carer (3/9 domains assessed), and the summary index of the PDQ-Carer 
(2/9 domains assessed). Internal Consistency was the most widely assessed measurement 
property, and was examined in all 7 instruments. Cronbach alpha coefficients for the total 
scale and instrument subscales ranged from 0.75 to 0.94 (see Table 3 for an overview of the 
psychometric properties of each carer QOL instrument).  
Reliability of the measures was reported in 4/8 studies. [6, 17, 19, 20] These studies 
computed test-retest reliability over a 2-3 week time interval through calculation of Pearson 
or Spearman correlations. Intraclass Correlation Coefficients (ICC) were also used to assess 
test-retest reliability of individual subscales in two instruments: the CAREQOL-MS and 
CGQOL. ICCs ranged between 0.53 and 0.95 for all subscales across these two measures. 
The CAREQOL-MS was the only instrument to calculate measurement error.  
Content Validity was evaluated in 5/8 studies. [17, 19, 20-22] Structural Validity was 
assessed in 7/8 studies. [6, 17-19, 21-23] Principal Components Analysis (PCA) was the most 
frequently employed method of statistical analysis for examining Structural Validity. No 
studies included the use of Confirmatory Factor Analysis with either continuous or 
categorical variables (aka Item Response Theory) to assess factorial structure.  
 Correlational and known group analyses were most commonly used to assess 
convergent and discriminant validity.  However, Hypotheses Testing was carried out for only 
two instruments; the HDQoL-C-SF [18] and the CGQOL [6]. Cross-Cultural Validity was 
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evaluated for three measures; the HDQoL-C-SF, [18] ACQLI, [20] and CGQOL. [6] None of 
the instruments assessed Criterion Validity or Responsiveness.    
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Table 3. Evidence of the reliability and validity of the carer QOL instruments  
       
  Reliability   Validity   
 
Carer QOL instrument 
 
Author(s) 
 
Internal consistency 
 
Test-retest 
 
Measurement error 
 
Content validity 
 
Construct validity  
 
Huntington disease 
quality-of-life battery 
for carers (HDQoL-C) 
 
Aubeeluck & 
Buchanan (2007) 
 
Not provided for total 
scale. 
Subscale α: 0.80, 0.84, 
0.89 
 
Test-retest (N=10) 
over 2 weeks. 
Pearson correlation: 
0.78, 0.86, 0.90 for 
subscales  
 
Not assessed 
 
Two experts in the 
field of QOL and 
two experts in the 
field of HD 
commented on item 
content. 
Convergent validity: 
Positive correlations of 
HDQoL-C subscales with 
WHOQOL-BREF, 
Satisfaction with Life 
Scale, and Perceived 
Health Visual Analogue 
Scale 
Huntington disease 
quality-of-life battery 
for carers short form 
(HDQoL-C-SF) 
Aubeeluck et al. 
(2012) 
Not provided for total 
scale. 
Subscale α: 0.88, 0.80 
Not assessed Not assessed Not assessed Known groups analyses 
showed that HDQoL-C-
SF scores were higher 
(better carer QOL) for 
carers of patients in the 
low disease severity 
group compared to the 
moderate and high 
severity groups 
CAREQOL-MS Benito-Leon et al. 
(2011) 
Not provided for total 
scale. 
Subscale α: 0.90, 0.85, 
0.81, 0.78, 0.75  
Test-retest (N=276) 
over 2 weeks. ICC for 
total scale score = 0.96 
and ranged from 0.75 
to 0.95 for subscales. 
Cohen’s Kappa ranged 
from 0.46 to 0.93. 1 
item had Kappa<0.60 
and 15 items had 
Kappa > 0.80. 
Standard Error of 
Measurement 
ranged from 0.91 to 
2.43 across the five 
subscales over 2 
week time interval. 
Item content 
analysed by MS 
experts. Focus 
groups of MS 
carers and patients 
discussed item 
pool. Items rated 
for clarity and 
meaning by MS 
experts and a 
separate carer 
sample.  
Convergent validity: 
Positive correlations of 
CAREQOL-MS subscales 
with Zarit Burden 
Interview. Moderate to 
high negative correlations 
of CAREQOL-MS 
subscales with physical 
and mental components of 
SF-36.  
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Table 3. Evidence of the reliability and validity of the carer QOL instruments (Continued)  
       
  Reliability   Validity   
 
Carer QOL instrument 
 
Author(s) 
 
Internal consistency 
 
Test-retest 
 
Measurement error 
 
Content validity 
 
Construct validity  
 
Alzheimer’s Carers 
Quality of Life 
Instrument (ACQLI) 
 
Doward (1997) 
 
α ranged between 0.87 
and 0.95 across the UK, 
France, Germany, Italy 
and Spain for Time 1 
and Time 2 
administrations of the 
ACQLI. 
 
Test-retest over 2 
weeks. Spearman 
correlations were 0.93, 
0.92, 0.95, 0.94, 0.90 
for UK, France, 
Germany, Italy and 
Spain, respectively. 
Based on very small N 
per country.  
 
Not assessed 
 
Field test of items 
with samples of 
carers. States that 
carers found the 
ACQLI to be 
understandable, 
acceptable and 
relevant across all 
countries.  
 
Convergent validity: 
Positive spearman 
correlations of ACQLI 
with General Wellbeing 
Index in UK and Italy. 
Known groups analysis 
demonstrated that the 
ACQLI can distinguish 
between carers based on 
their current health status. 
Parkinson Disease 
Questionnaire for 
Carers (PDQ-Carer) 
Jenkinson et al. (2012) Not provided for total 
scale. 
Subscale α: 0.92, 0.87, 
0.86, 0.83 
Not assessed Not assessed Very limited 
assessment of 
content validity. 
Items were 
evaluated by focus 
groups of 
researchers and a 
pilot sample of 
carers. 
Convergent validity: 
Moderate to high negative 
correlations of PDQ-Carer 
subscales with physical 
and mental components of 
SF-36. 
 
Parkinson Disease 
Questionnaire for 
Carers Summary Index 
(PDQ-Carer-SI) 
 
Morley et al. (2013) 
 
α = 0.94  
 
Not assessed 
 
Not assessed 
 
Not assessed 
 
Convergent validity: 
Moderate to high negative 
correlations of PDQ-Carer 
Summary Index score 
with physical and mental 
components of SF-36.   
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Table 3. Evidence of the reliability and validity of the carer QOL instruments (Continued)  
       
  Reliability   Validity   
 
Carer QOL instrument 
 
Author(s) 
 
Internal consistency 
 
Test-retest 
 
Measurement error 
 
Content validity 
 
Construct validity  
 
Parkinsonism Carers 
QoL (PQoL Carers)  
 
Pillas et al. (2016) 
 
α = 0.96 
 
Not assessed  
 
Not assessed 
 
Very limited 
assessment of 
content validity. 
The questionnaire 
was pilot tested in a 
small group of 
carers.  
 
Convergent validity: 
Subscales of PQoL Carers 
correlated with Caregiver 
Burden Inventory, 
Hospital Anxiety and 
Depression Scale and the 
EQ-5D. ANOVA 
revealed that PQoL 
Carers scores differentiate 
between carers based on 
their current health status.  
Caregiver Quality Of 
Life (CGQOL) 
Vickrey et al. (2009) Not provided for total 
scale. 
Subscale α: 0.88, 0.93, 
0.78, 0.83, 0.86, 0.86, 
0.82, 0.94, 0.92, 0.89 
Test-retest (N=71) 
between 11 and 63 
days following first 
administration (75% 
within 21 days). ICC 
ranged from 0.53 to 
0.89, exceeding 0.70 
for 6 of the 10 
subscales. 
Not assessed Not assessed Convergent validity: 
Regression and 
correlation analyses of 
CGQOL subscales with a 
range of patient and carer 
characteristics (e.g. 
number of hours spent 
caregiving, duration of 
being a carer) 
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Constructs Assessed by the Carer Quality of Life Instruments 
Huntington’s disease    
As displayed in Table 3, the HDQoL-C consists of four measurement domains 
(demographic and objective information; practical aspects of caregiving; satisfaction with 
life; feelings about living with Huntington’s disease) which assess the QOL of spousal carers 
of people with Huntington’s disease (HD). It is a 34-item instrument which employs an 11-
point Likert-type response scale. PCA using varimax rotation was performed separately on 
each set of items for three of the four domains (not the component of demographic and 
objective information). This identified three subcomponents for the first component of 
“practical aspects of care-giving” (levels of support and access to professionals; long-term 
and genetic issues; daily hassles). PCA on the third domain of “satisfaction with life” 
extracted two subcomponents (overall QOL issues; personal issues). Finally, PCA on the 
fourth domain of “feelings about living with HD” resulted in the identification of two 
subcomponents (negative feelings about life; positive feelings about life).           
The short form of the HDQoL-C measures two of the four domains of the original 
instrument (satisfaction with life; feelings about living with HD). It is a 20-item measure 
using an 11-point Likert-type response scale. Exploratory factor analysis using varimax 
rotation was performed on the 17 items of the “feelings about living with HD” subscale. This 
resulted in the extraction of the two subcomponents of “negative feelings about life” and 
“positive feelings about life” which accounted for 84% of the total variance. Factor analysis 
was not performed on the “satisfaction with life” subscale as only three items were retained 
from the full length measure. In addition to the English language version of the HDQoL-C, 
the measure was translated into French and Italian.  
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Multiple Sclerosis   
The CAREQOL-MS measures QOL in carers of people with Multiple Sclerosis (MS). 
It consists of 24 items and uses a 5-point Likert-type response format. PCA using orthogonal 
rotation (unspecified method of rotation) extracted four factors identified as “physical burden 
and global health”, “emotional impact”, “need of support” and “emotional reactions to 
patient’s psychic status” explaining 60% of the total variance. The first factor was later 
subdivided to include a separate subscale of “social impact.”  
 
Parkinson’s disease 
The PDQ-Carer measures QOL in carers of people with Parkinson’s Disease (PD). 
This instrument contains 29 items and uses a 5-point Likert-type response format. 
Exploratory factor analysis using varimax rotation identified four factors: social and personal 
activities, anxiety and depression, self-care, and stress. These factors explained 60% of the 
total variance. 
The PQoL Carers is an alternative measure of QOL in family carers of people with 
PD. This instrument contains 26 items and uses a 5-point Likert-type response format. 
Parallel analysis was performed to assess the dimensionality of the scale which identified a 
single factor structure (representing overall QOL), explaining 54% of the total variance.  
 
Dementia and Alzheimer’s disease  
The ACQLI measures QOL in carers of people with Alzheimer’s disease and 
dementia. This instrument consists of 30 items which use a dichotomous (True/Not True) 
response format. Structural validity of the ACQLI has not been evaluated. The items of the 
measure assess QOL as a unidimensional construct, but no factor analysis was reported in the 
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development of this scale. Five language versions of the ACQLI are available; English, 
French, German, Italian, and Spanish.  
Finally, the CGQOL is the most recently developed measure of QOL in carers of 
people with dementia and Alzheimer’s disease. The instrument contains 80 items across ten 
domains (assistance with instrumental activities of daily living; assistance with activities of 
daily living; role limitations due to caregiving; personal time; family interaction; demands of 
caregiving; worry; spirituality and faith; benefits of caregiving; caregiver feelings) using 
either a 3-point or a 5-point Likert-type response format, with categories specific to groups of 
items. These ten subscales were categorised under three superordinate factors labelled 
“Tangible Assistance” (comprised of assistance [to the person with dementia] with 
instrumental activities of daily living; assistance [to the person with dementia] with activities 
of daily living; personal time; role limitations due to caregiving), “Psychosocial” (comprised 
of role limitations due to caregiving [cross-loaded with Tangible Assistance]; family 
involvement; demands of caregiving; worry; caregiver feelings), and “Benefits/Faith” 
(comprised of spirituality and faith, and benefits of caregiving) using exploratory factor 
analysis with promax rotation. The CGQOL was originally developed in English and was 
later translated into Spanish. It is noted that items were translated into Spanish, reviewed by a 
second translator, and interviews were then conducted with eight Spanish-speaking carers in 
which to assess and refine item wording. 
                                
DISCUSSION 
We identified eight studies which report the development of seven carer QOL 
measures in neurodegenerative diseases (i.e. dementia and Alzheimer’s disease; Huntington’s 
disease; Parkinson’s disease; Multiple Sclerosis). No instruments were identified that 
measure carer QOL in motor neurone disease. The findings of the studies, taken together, are 
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potentially of value in guiding researchers and health professionals in the selection of an 
appropriate and psychometrically robust disease-specific instrument. The studies demonstrate 
some key methodological problems in the current instruments available to measure carer 
QOL in these neurodegenerative diseases and highlight avenues for future research.  
Overall, limited information was available concerning the psychometric properties of 
the instruments that were identified. Collectively, the studies have shown that many 
important elements of psychometric evaluation were either absent or not sufficiently tested 
during the development phases of these disease-specific measures. This review found that the 
CAREQOL-MS [19] and the CGQOL [6] received the most comprehensive psychometric 
evaluation, whereas the PQoL Carers [22] and the PDQ-Carer [21] (including the validation 
of the summary index [23]) had the least information available on their psychometric 
properties.  
Internal consistency was the most widely reported psychometric property and was 
available for all seven instruments. This was quite strong across the studies with Cronbach 
alpha coefficients ranging from 0.75 to 0.94. Less information was provided for the temporal 
stability of the measures. Only four of the instruments reported test-retest reliability 
(HDQoL-C, CAREQOL-MS, ACQLI, CGQOL), and this ranged from being adequate to 
excellent over a 2-3 week period. The CAREQOL-MS was the only instrument to report 
measurement error, which is the more useful figure than reliability since it controls for the 
population variance and is therefore more readily generalizable to other populations. [24]   
The assessment of factorial structure was generally limited across all studies. 
Exploratory factor analysis (EFA) and principal components analysis (PCA) were the 
methods predominantly used by the test developers to assess dimensionality. However, no 
factor analysis was reported for the development of the ACQLI, despite the underlying 
assumption that it is a unidimensional measure of carer QOL.  Moreover, none of the studies 
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had performed confirmatory factor analysis (CFA) as a hypothesis-driven test of structural 
validity. All identified studies disregarded the categorical nature of responses and treated 
them as continuous for the purposes of factor analysis. While this approximation may be 
acceptable for items using five or more categories, [25] it is generally untenable for 
dichotomous items [24] such as used in the ACQLI. Future research using these instruments 
should investigate whether the factor structures that were identified in EFA will replicate in 
CFA when the fit of alternative measurement models are tested. It would also be 
advantageous for researchers to explore factorial structures using methods for categorical 
variables (Item Response Theory [IRT]), such as Rasch analysis. [26] A strong advantage of 
Rasch analysis is that different measures of the same attribute can be calibrated using the 
same scale and items can be used for computerized adaptive testing. [27] IRT methods can 
thus control for item properties that are difficult in classical measurement, such as the item 
difficulty or ability to discriminate between varying levels of the attribute. 
Interestingly, the factor analyses reported in the studies reviewed suggest that similar 
constructs are being measured by all carer QOL instruments across the various diseases. 
These measurement domains include, for example, an appraisal of caring demands, 
evaluation of support received, positive and negative feelings toward caring, the social impact 
of caring and negative health effects due to caring, such as anxiety, depression, stress and 
fatigue. In contrast to the other measures, the CGQOL includes a wider array of QOL 
domains believed to be affected by the caring role such as role limitations and family 
interaction.  
Correlations with external measures were examined in all seven instruments. As 
evidence of convergent validity, the disease-specific measures were often found to correlate 
with generic measures of QOL such as the SF-36 and the EQ-5D. [19, 21-23] Known groups 
analysis was frequently used to evaluate construct validity. For example, the HDQoL-C-SF 
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differentiated between carers on the basis of the patients’ disease severity. As reported 
previously, it was shown that carers’ scores on the HDQoL-C-SF were higher (i.e. 
representing better QOL) when caring for family members whose Huntington’s disease was 
less severe. [18]  
A limitation of the studies reviewed is that hypotheses were not formulated in the 
assessment of construct validity. The HDQoL-C-SF and CGQOL were the only two 
instruments in which hypotheses had been postulated a priori about the expected relationships 
among measures. As such, it was unclear how researchers had anticipated their measures to 
be associated with, or distinct from, existing scales that measure similar constructs. Another 
limitation of the studies included in the review is that criterion-related validity had not been 
examined or even considered as an important issue. More importantly, none of the 
instruments that we examined had assessed responsiveness to change. Thus, it is not known 
whether these instruments are sensitive to detecting changes in carers’ QOL over time. 
Researchers and clinicians need to measure whether interventions and services are effective 
in improving carer QOL. The lack of known responsiveness to change in these existing 
measures could, therefore, be problematic for those seeking to administer these measures 
within intervention programmes and social care settings. The growing use of QOL as a 
primary outcome measure in interventional studies highlights the importance of conducting 
responsiveness analysis on these measures and including such analyses in the development of 
future QOL instruments. 
 
Limitations 
There are several limitations of the present review that warrant consideration. First, 
only articles written in English were sourced, and this may have led to the exclusion of carer 
QOL measures that were developed and/or validated in other languages. Second, this review 
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only focused on neurodegenerative diseases and did not examine the psychometric properties 
of carer QOL measures developed for other medical conditions. For example, the Caregiver 
Quality of Life Index-Cancer (CQOLC; 28) scale is a self-report measure of QOL in family 
carers of patients with cancer. In future research, it would be interesting to compare the 
psychometric properties of neurodegenerative disease-specific measures with carer QOL 
instruments across a broader range of disorders. Third, we only examined the measurement of 
QOL of family carers (defined for our purposes as family members, neighbours or friends) 
and did not consider professional (paid) carers. It should be noted, however, that no articles in 
this review were excluded during the screening process on the basis of the carer samples that 
were reported. It appears that there are no instruments developed to measure the specific 
QOL impacts on paid carers. Our systematic review appears to have been successful in 
detecting carer QOL measures that currently exist across the various neurodegenerative 
diseases.  
 
CONCLUSIONS  
In this systematic review, we provide a comprehensive overview of disease-specific  
instruments to measure QOL of family carers of people with a neurodegenerative disease. 
The included studies had key methodological limitations associated with the measurement of 
QOL using these disease-specific instruments. These findings indicate that there is a need to 
further develop and refine these measures and potentially to develop new measures, in order 
to improve the psychometric quality of the measures available. Given the considerable 
overlap in the constructs measured by the QOL instruments that we reviewed, it might be 
useful for researchers to explore whether a single measure of carer QOL for all 
neurodegenerative diseases would be feasible and valid. However, due to the heterogeneity in 
symptoms and disease course, a rigorous development process is needed before assuming a 
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single measure would be sufficient. Moreover, it would be advantageous to create shorter and 
more concise measures of carer QOL. This would offer greater brevity and flexibility to 
researchers and clinicians who need to administer these instruments in tandem with a number 
of other scales. Long instruments such as the 80-item CGQOL [6] arguably impose a greater 
burden on respondents. Thus, shorter measures that contain fewer items would benefit 
respondents by reducing completion time and reporting burden.  
Overall, the findings of this review should be helpful in guiding researchers and 
health professionals in the selection of an appropriate, and psychometrically robust, disease-
specific instrument. The accurate assessment of carer QOL is a growing research priority, and 
the findings of this review are a useful foundation for researchers seeking to develop and 
validate new measures of carer QOL in neurodegenerative disorders. The development of 
psychometrically strong, disease-specific measures of QOL is important for the generation of 
better treatments, services, care and support for people with neurodegenerative disorders and 
their carers. As demonstrated in this review, there are few instruments that measure carer 
QOL in neurodegeneration, and the psychometric properties of the few available measures 
are limited. Further psychometric testing is needed on existing measures; future validation 
studies should include the use of IRT in conjunction with traditional methods of assessment.  
There is room for new instruments with stronger psychometric development, evaluation and 
properties in this important area.                
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
flow diagram of study selection. 
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